Colorectal cancer (CRC), the 3rd most common global malignancy, has high morbidity and mortality, with only 15% 5-year survival for metastatic CRC (mCRC), and early-onset cases are rising worldwide.

Recent breakthroughs are transforming care through innovative screening and diagnosis, improved surgical techniques, targeted therapies, immunotherapies, and the advancement of cellular therapies. This book synthesizes cutting-edge CRC insights in diagnosis, screening, and treatment, providing clinicians, researchers, patients, and caregivers with pivotal knowledge that shapes survival outcomes.